The Kanabo share price: should I get involved or steer clear?

After a strong first week since the IPO, the Kanabo share price is up around 400%. Jonathan Smith finds out more about this wellness cannabis stock.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

3D Word IPO with Target on Chalkboard Background

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Kanabo Group (LSE:KNB) share price has performed exceptionally well in the first week of trading following the IPO last week. From an issue price of 6.5p, the shares closed last Friday at 31p. This reflects a gain of almost 400%. The first few weeks of a new stock trading on the LSE are usually volatile. Yet even by IPO standard, this was a big move. So what’s the story here, and should I look to buy?

The backstory on Kanabo

Kanabo manufactures CBD products, marijuana pods and inhalers, and other similar items. It says that all the cannabis and other drug-related products are purely for medicinal purposes and wellness. Although Kanabo shares are unlikely to be included in any ESG investors portfolio, it’s technically legal. Cannabis (for medical use) was legalised in the UK back in 2018. Regulators have also given the green light for these types of companies to list on the LSE.

It thus became the first medical cannabis company to go public here in the UK. Given the Kanabo share price performance in the first week, I’d say it’s been a success so far. The company finds itself with a market capitalisation of around £112m. The funds raised from the IPO are going to be ploughed back into product development.

Could the Kanabo share price head higher?

Firstly, let’s look at the size of the market. There’s no question that the cannabis market is growing globally. More countries are legalising it, leading to forecasts that in Europe and the UK, the market could be worth £1.7bn over the next four years. Clearly, Kanabo is in a good position to reap the benefits of this growth. On the other hand, the market is still relatively new here in Britain. There’s no blueprint for Kanabo to follow.

As a company that’s just listed, it’s hard for me to find all the financial details to give me more insight. A private limited company doesn’t have to share as much financial info as a public one does. From what I can find, the business is loss-making. The latest loss after tax for the 2019 period was £360k. Without more detailed financial reporting, I can’t glean much aside from that. And investing in a company that has been losing money doesn’t seem a smart play.

Given the size of Kanabo, I think the share price could head higher as it could become a takeover target. A larger pharmaceutical company that sees the growth potential in this sector could look to buy it. Depending on the premium put on the Kanabo share price at that time, shareholders could see a large profit from buying now. But that’s not guaranteed, of course.

As I’ve flagged in recent IPO articles on Bumble and Moonpig, I’m not a fan of investing just after an IPO. This is the same risk with Kanabo. I’d much prefer to sit on the sidelines for a month and see where the share price settles before making a move. This reduces my chances of large losses during the volatile initial trading period.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

jonathansmith1 has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

How I’d use an empty Stocks and Shares ISA to aim for a £1,000 monthly passive income

Here's how using a Stocks and Shares ISA really could help those of us who plan to invest for an…

Read more »

Investing Articles

This FTSE stock is up 20% and set for its best day ever! Time to buy?

This Fool takes a look at the half-year results from Burberry (LON:BRBY) to see if the struggling FTSE stock might…

Read more »

Investing Articles

This latest FTSE 100 dip could be an unmissable opportunity to pick up cut-price stocks

The FTSE 100 has pulled back with the government’s policy choices creating some negative sentiment. But this gives us a…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

As the WH Smith share price falls 4% on annual results, is it still worth considering?

WH Smith took a hit after this morning’s results left shareholders unimpressed. With the share price down 4%, Mark Hartley…

Read more »

Investing Articles

The Aviva share price just jumped 4.5% but still yields 7.02%! Time to buy?

A positive set of results has put fresh life into the Aviva share price. Harvey Jones says it offers bags…

Read more »

Investing Articles

Can a €500m buyback kickstart the Vodafone share price?

The Vodafone share price has been a loser for investors in recent years, and the dividend has been cut. We…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Growth Shares

3 mistakes I now avoid when choosing which growth stocks to buy

Jon Smith runs through some of the lessons he's learnt the hard way over the years about what to look…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Should I follow Warren Buffett and sell my favourite shares?

Billionaire US investor Warren Buffett has been selling tons of Apple shares and other stocks of businesses he thinks are…

Read more »